Could a blood pressure drug ease chest pain in people with clear arteries?

NCT ID NCT07670091

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at whether bosentan, a drug that blocks a natural vessel-constricting substance, can improve blood flow in the tiny heart vessels of people with angina who have no major blockages. About 45 participants will get bosentan for 4 weeks and have MRI scans before and after. The goal is to understand if this approach could lead to new treatments for microvascular angina.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Bosentan (endothelin receptor antagonist)
What this could lead to
If it works, this could point toward a new treatment for angina caused by small vessel problems, not just blocked arteries.
What could go wrong
This is a very small, early study (45 people) looking at blood flow changes, not symptoms. Bosentan may not improve angina or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANGINA PECTORIS WITH NORMAL CORONARY ARTERIOGRAM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NHS University Hospitals of Liverpool Group

    Liverpool, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.